摘要
目的分析进行直接抗人球蛋白试验（DAT）患者的检测结果，了解DAT阳性结果疾病的分布情况。方法收集65例DAT阳性结果患者的临床资料，回顾性分析其疾病与检测结果的关系。结果临床诊断“贫血原因待查”患者DAT阳性率最高，占所有阳性患者的49．2％（32／65），其他DAT阳性患者的疾病基本符合文献报道。结论血清DAT检查虽然不能确定患者是否有溶血性贫血，但是可以帮助鉴定溶血是否有免疫基础，从而有利于临床治疗以及选择适宜的时间输注适宜的血液成分。
Objective To analyze the direct anti-human sphere test （DAT）results of 170 patients with a high clinical suspicion of autoantibody; to understand the positive results of DAT distribution of the disease. Methods We collected the clinical data of 65 patients with DAT-positive results, then retrospectively analyzed the relationship between disease and test results. Results The positive rate of clinical diagnosis of ＂anemia of unknown origin＂ DAT patients was the highest （49.2% of total positive patients）. Conclusions Although serological tests can not determine the DAT patients with hemolytic anemia, but it can help to identify whether there is an immune hemolytic basis. Accordingly it can help to decide the appropriate time and the appropriate blood component
出处
《中国医药》
2012年第10期1282-1283,共2页
China Medicine
